InMed Appoints Dr. David G. Morgan, PhD, a Leading Alzheimer's Expert, to the Company's Scientific Advisory Board

InMed Pharmaceuticals Inc. , a leader in the research, development, manufacturing, and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today announced the addition of Dr....

Related Keywords

Vancouver ,British Columbia ,Canada ,United Kingdom ,British ,Colin Clancy ,Davidg Morgan ,Eric Hsu ,Inmed Pharmaceuticals ,University Of Southern California ,Nasdaq ,Byrd Alzheimer Institute ,Alzheimer Association ,University Of South Florida ,Corporate Communications ,British Columbia Newsfile Corp ,Alzheimer Alliance ,Preclinical Drug Development ,Northwestern University ,Exchange Commission ,Morgan ,Inmed Pharmaceuticals Inc ,Med Pharmaceuticals ,Scientific Advisory Board ,David Morgan ,Translational Neuroscience ,Michigan State ,Byrd Alzheimer ,Community Based Memory Screening ,Southern California ,South Florida ,Researchers Against Alzheimer ,Investor Relations ,Note Regarding Forward Looking Information ,Annual Report ,